VIDPREVTYN BETA, solution and emulsion for injectable emulsion. vaccine against COVID-19 (recombinant with adjuvant) 100 doses
Active ingredients: PROTÉINE SPIKE RECOMBINANTE DU SARS-COV-2 - SOUCHE B.1.351
Commercialized according to BDPMDispensing in France: Prescription only
Solution and emulsion for injectable emulsion100 dosesintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIDPREVTYN BETA, solution et émulsion pour émulsion injectable. Vaccin contre la COVID-19 (recombinant avec adjuvant)
- Pharmaceutical form
- solution et émulsion pour émulsion injectable
- Route of administration
- intramusculaire
- Presentation description
- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL- 10 flacon(s) multidose(s) de 10 doses en verre de 2,5 mL (100 doses),
- Marketing authorisation holder
- SANOFI PASTEUR
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67734275CIP73026415CIP133400930264157Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROTÉINE SPIKE RECOMBINANTE DU SARS-COV-2 - SOUCHE B.1.351solution | 5 microgrammes · une dose de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.